Impact of reactivation on the sequelae of multi-system Langerhans cell histiocytosis patients

被引：9
|
作者：
Morimoto, Akira [1 ]
Kobayashi, Ryoji [2 ]
Maeda, Miho [3 ]
Asami, Keiko [4 ]
Bessho, Fumio [5 ]
Imashuku, Shinsaku [6 ]
机构：
[1] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan
[3] Nippon Med Coll, Dept Pediat, Tokyo 113, Japan
[4] Niigata Canc Ctr, Div Pediat, Niigata, Japan
[5] Kyorin Univ, Sch Med, Dept Pediat, Tokyo, Japan
[6] Takasago Seibu Hosp, Div Pediat, Takasago, Hyogo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2008年 / 50卷 / 04期
关键词：
D O I：
10.1002/pbc.21315
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：931 / 932
页数：2
相关论文
共 50 条
  • [21] DEVELOPMENT OF RHEUMATOID ARTHRITIS DURING THE LONG TIME COURSE OF MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS
    Tiganova, Olga
    Bronin, Gleb
    Kondratchik, Konstantin
    Kovaliova, Olga
    PEDIATRIC BLOOD & CANCER, 2011, 56 (04) : 691 - 691
  • [22] Vaccine Associated Soft Tissue Infiltrate Can Predispose Multi-System Langerhans Cell Histiocytosis
    Bronin, Gleb
    Kislyakov, Alexey
    Kondratchik, Konstantin
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S2 - S2
  • [23] Langerhans Cell Histiocytosis Reactivation in a Teenager
    Ramji, Husayn F.
    Deng, Francis
    JOURNAL OF PEDIATRICS, 2022, 248 : 131 - 132
  • [24] LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN - TREATMENT OF PATIENTS WITH REACTIVATION OF DISEASE
    Glamocanin, G.
    Antevska, A.
    Coneska, B.
    Martinova, M.
    Koceva, K.
    Petrusevska, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 691 - 691
  • [25] Importance of Multi-lineage Hematologic Involvement and Hypoalbuminemia at Diagnosis in Patients With "Risk-organ" Multi-system Langerhans Cell Histiocytosis
    Luis Braier, Jorge
    Rosso, Diego
    Latella, Antonio
    Chantada, Guillermo
    Ozuna, Blanca
    Ripoli, Mario
    Scopinaro, Marcelo
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (04) : E122 - E125
  • [26] Biomodulatory therapy induces long-lasting remissions in chemorefractory multi-system Langerhans cell histiocytosis
    Harrer, D. C.
    Jakob, M.
    Vogelhuber, M.
    Lueke, F.
    Rehe, K.
    Corbacioglu, S.
    Herr, W.
    Reichle, A.
    Heudobler, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 183 - 183
  • [27] MAPPING NON-BRAFV600E HEMATOPOIETIC CLONES IN MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS
    Milne, Paul
    Abhyankar, Harshal
    Scull, Brooks
    Singh, Preeti
    Chakraborty, Rikhia
    Collin, Matthew
    Allen, Carl E.
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [28] Bortezomib alone or in combinination with Doxil is active in adult refractory multi-system Langerhans cell histiocytosis (LCH)
    Haddad, Philip A.
    BLOOD, 2007, 110 (11) : 27B - 27B
  • [29] Activity of Bortezomib alone or in combination with Doxil in adult refractory multi-system Langerhans cell histiocytosis (LCH)
    Haddad, Philip A.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 869 - 869
  • [30] Adult Langerhans cell histiocytosis with multi-system bone, skin, lung and liver involvement: A case report
    Lei, Qiucheng
    Hong, Xitao
    Yuan, Jianxiang
    Zheng, Huazhen
    Deng, Feiwen
    BIOMEDICAL REPORTS, 2024, 21 (05)
12345